Analysts at JMP Securities upgraded Infinity Pharmaceutical (INFI) from a ‘Market Perform’ rating to a ‘Market Outperform’ rating in a research note issued to investors on Thursday. Infinity shares recently declined 1.2% to $15.61. The stock is down more than 22% this year and has gained roughly 15% over the past 9 months. In the […]
View the full post at: Notable Upgrades: Infinity Pharmaceuticals (INFI), IAC/InterActiveCorp (IACI), Cerner Corporation (CERN), DR Horton (DHI), Amazon.com (AMZN)